FDA Approved: CEPHALEXIN — Supplemental Application (AVKARE)

View source ↗

Summary

FDA approved a supplemental application for Cephalexin submitted by AVKARE, indicating an approved modification to this product's label or authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media
• Skin and Soft Tissue Infections
• Streptococcal Pharyngitis
• Urinary Tract Infection

Drugs mentioned

• Cephalexin (Cephalexin)

Snippet

SUPPL AP for CEPHALEXIN (CEPHALEXIN)